newsfilter
← Latest News
Business Wire·

Catalent Stockholders Approve Transaction with Novo Holdings

Catalent, Inc. (("Catalent, NYSE:CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, today announced that, at its Special Meeting of Stockholders (the "Special Meeting")